KalVista Pharmaceuticals
Insider trading & Transactions

Last updated:

Transaction Date Insider Security Shares Price per share Total value Source
Option
YEA CHRISTOPHER officer: Chief Development Offi..
 Common Stock 600 $17.01 $10,205
Option
YEA CHRISTOPHER officer: Chief Development Offi..
 Common Stock 1,302 $0 $5
Option
YEA CHRISTOPHER officer: Chief Development Offi..
 Employee Stock Option (Right to Buy) 1,302 $0 $5
Sale
YEA CHRISTOPHER officer: Chief Development Offi..
 Common Stock 1,302 $0 $5
Sale
FEENER EDWARD P. officer: Chief Scientific Officer
 Common Stock 4,000 $19.51 $78,024
Sale
CROCKETT THOMAS ANDREW director, officer: CEO
 Common Stock 10,000 $19.57 $195,710
Sale
SVLSF IV, LLC 10 percent owner
 Common Stock 2,599 $20.41 $53,051
Sale
SVLSF IV, LLC 10 percent owner
 Common Stock 1,700 $20.01 $34,022
Sale
SVLSF IV, LLC 10 percent owner
 Common Stock 200 $20 $4,000
Sale
SVLSF IV, LLC 10 percent owner
 Common Stock 25,418 $20 $508,462
Sale
SVLSF IV, LLC 10 percent owner
 Common Stock 3,734 $20.03 $74,781
Sale
SVLSF IV, LLC 10 percent owner
 Common Stock 2,136 $20.02 $42,758
Purchase
ORONSKY ARNOLD L director
 Common Stock 58,824 $17 $1,000,008
Purchase
CHA ALBERT director
 Common Stock 1,058,824 N/A N/A
Sale
NOVO HOLDINGS A/S 10 percent owner
 Common Stock 1,726,481 $9.26 $15,987,214
Purchase
SHAH RAJEEV M. director, 10 percent owner
 Common Stock 850,000 $8.5 $7,225,000
Purchase
RA CAPITAL MANAGEMENT, LLC director, 10 percent owner
 Common Stock 850,000 $8.5 $7,225,000
Purchase
ALDRICH RICHARD director
 Common Stock 565,065 N/A N/A
Sale
NOVO HOLDINGS A/S 10 percent owner
 Common Stock 35,519 $10.21 $362,756
Sale
NOVO HOLDINGS A/S 10 percent owner
 Common Stock 963,283 $12.78 $12,309,793
Sale
NOVO HOLDINGS A/S 10 percent owner
 Common Stock 140,747 $7.5 $1,055,884
Sale
NOVO HOLDINGS A/S 10 percent owner
 Common Stock 10,000 $8.05 $80,500
Sale
NOVO HOLDINGS A/S 10 percent owner
 Common Stock 25,900 $8.02 $207,614
Option
RENZI DAVID director, officer: President & ..
 Stock Option (Right to Buy) 36,640 $7.84 $287,258
Option
RENZI DAVID director, officer: President & ..
 Common Stock 36,640 $7.84 $287,258
Option
MARONEY MARCEE officer: VP, Clinical Affairs
 Stock Option (Right to Buy) 2,592 $7.84 $20,321
Option
MARONEY MARCEE officer: VP, Clinical Affairs
 Common Stock 4,664 $7.84 $36,566
Option
BASTA STEVEN L director
 Common Stock 1,125 $7.84 $8,820
Option
BASTA STEVEN L director
 Stock Option (Right to Buy) 1,125 $7.84 $8,820
Option
RENZI DAVID director, officer: President & ..
 Stock Option (Right to Buy) 10,000 $0.56 $5,600
Option
RENZI DAVID director, officer: President & ..
 Common Stock 10,000 $0.56 $5,600
Sale
RENZI DAVID director, officer: President & ..
 Common Stock 10,000 $0.56 $5,600
Purchase
ACMP IV LLC 10 percent owner
 Common Stock 877,500 $5 $4,387,500
Purchase
VIVO VENTURES VI, LLC 10 percent owner
 Common Stock 2,025,000 $5 $10,125,000
Purchase
CHA ALBERT
Common Stock 2,025,000 $5 $10,125,000
Purchase
CHA ALBERT
Common Stock 2,025,000 $5 $10,125,000
Purchase
INTERWEST MANAGEMENT PARTNERS IX, LLC 10 percent owner
 Common Stock 810,000 $5 $4,050,000
Purchase
CHA ALBERT
Common Stock 2,025,000 $5 $10,125,000
Purchase
NOHRA GUY P director
 Common Stock 877,500 $5 $4,387,500
Purchase
VIVO VENTURES VI, LLC 10 percent owner
 Common Stock 2,025,000 $5 $10,125,000

Showing 400 to 440 of 440 results.

Insider trading

Monitoring trades made by the management members or major shareholders of companies may help create a sharper picture of what is happening inside the companies. Base your decisions on buys or sells of the people involved and do the right thing at the right time.

Who is insider?

Every director or senior officer, as well as any other entity or individual owning more than 10% of the company’s shares on the stock market, is called an insider. Such people or entities are allowed to buy/sell the company's shares under strictly controlled conditions. Key premise here is that none of them can make trades based on non-public information about the company.

Similar companies insider trading: